The purpose of this study is to evaluate the feasibility, safety, and preliminary efficacy of
integrating targeted dosing of intranasal oxytocin with a social cognitive skills group
therapy for school-aged children with autism spectrum disorder (ASD).
Phase:
Phase 2
Details
Lead Sponsor:
Rush University Medical Center
Collaborators:
Eotvos Lorand University Northwestern University University of Chicago University of Illinois at Chicago